Journal
DEVELOPMENTAL CELL
Volume 53, Issue 1, Pages 9-+Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2020.02.015
Keywords
-
Categories
Funding
- NIH Director's Pioneer award [DP1DK098059]
- MOD [1-FY17-788]
- NCI [R01CA217608]
- China Scholarship Council Award
- California Institute for Regenerative Medicine pre-doctoral fellowship
- Broad Stem Cell Research Center
Ask authors/readers for more resources
The mouse embryo undergoes compaction at the 8-cell stage, and its transition to 16 cells generates polarity such that the outer apical cells are trophectoderm (TE) precursors and the inner cell mass (ICM) gives rise to the embryo. Here, we report that this first cell fate specification event is controlled by glucose. Glucose does not fuel mitochondria! ATP generation, and glycolysis is dispensable for blastocyst formation. Furthermore, glucose does not help synthesize amino acids, fatty acids, and nucleobases. Instead, glucose metabolized by the hexosamine biosynthetic pathway (HBP) allows nuclear localization of YAP1. In addition, glucose-dependent nucleotide synthesis by the pentose phosphate pathway (PPP), along with sphingolipid (S1P) signaling, activates mTOR and allows translation of Tfap2c. YAP1, TEAD4, and TFAP2C interact to form a complex that controls TE-specific gene transcription. Glucose signaling has no role in ICM specification, and this process of developmental metabolism specifically controls TE cell fate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available